Petros Pharmaceuticals (PTPI) announces a new collaboration with Lemonaid Health, telemedicine provider and a subsidiary of 23andMe (ME), serving hundreds of thousands of patients with quality healthcare. As part of the collaboration, prescription STENDRA in all strengths will be available through Lemonaid Health’s telehealth platform. This collaboration allows Lemonaid Health to work directly with Petros, resulting in expanded distribution, and better access for patients.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTPI: